ReviewClinical and molecular hepatology2016

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy.

Ioannis Varbobitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.